This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quéva, C. Articles by Eisenman, R. N. Search for Related Content PubMed PubMed Citation Articles by Quéva, C. Articles by Eisenman, R. N.

Dwarfism and Dysregulated Proliferation in Mice Overexpressing the MYC Antagonist MAD1¹

Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024

The four members of the MAD family are bHLHZip proteins that heterodimerize with MAX and act as transcriptional repressors. The switch from MYC-MAX complexes to MAD-MAX complexes has been postulated to couple cell-cycle arrest with differentiation. The ectopic expression of Mad1 in transgenic mice led to early postnatal lethality and dwarfism and had a profound inhibitory effect on the proliferation of the hematopoietic cells and embryonic fibroblasts derived from these animals. Compared to wild-type cells, Mad1 transgenic fibroblasts arrested with altered morphology and reduced density at confluence, cycled more slowly, and were delayed in their progression from G₀ to the S phase. These changes were accompanied by accumulation of hypophosphorylated retinoblastoma protein and p130. Cyclin D1-associated kinase activity was dramatically reduced in MAD1-overexpressing fibroblasts. However, wild-type cell-cycle distribution and morphology could be rescued in the Mad1 transgenic cells by the introduction of HPV-E7, but not an E7 mutant incapable of binding to pocket proteins. This indicates that the activities of the retinoblastoma family members, via the cyclin D pathway, are likely to be the major targets for MAD1-mediated inhibition of proliferation in primary mouse fibroblasts.

This article has been cited by other articles:

				S. Rottmann, S. Speckgens, J. Luscher-Firzlaff, and B. Luscher Inhibition of apoptosis by MAD1 is mediated by repression of the PTEN tumor suppressor gene FASEB J, April 1, 2008; 22(4): 1124 - 1134. [Abstract] [Full Text] [PDF]

				K. Jiang, N. Hein, K. Eckert, J. Luscher-Firzlaff, and B. Luscher Regulation of the MAD1 promoter by G-CSF Nucleic Acids Res., March 1, 2008; 36(5): 1517 - 1531. [Abstract] [Full Text] [PDF]

				C. W. Hooker and P. J. Hurlin Of Myc and Mnt J. Cell Sci., January 15, 2006; 119(2): 208 - 216. [Abstract] [Full Text] [PDF]

				A. Hultquist, C. Cetinkaya, S. Wu, A. Castell, A. Erlandsson, and L.-G. Larsson Mad 1 Inhibits Cell Growth and Proliferation but Does Not Promote Differentiation or Overall Survival in Human U-937 Monoblasts Mol. Cancer Res., August 1, 2004; 2(8): 464 - 476. [Abstract] [Full Text] [PDF]

				H. Shen, G. Huang, M. Hadi, P. Choy, M. Zhang, G. Y. Minuk, Y. Chen, and Y. Gong Transforming growth factor-{beta}1 downregulation of Smad1 gene expression in rat hepatic stellate cells Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G539 - G546. [Abstract] [Full Text] [PDF]

				M. A. Nikiforov, N. Popov, I. Kotenko, M. Henriksson, and M. D. Cole The Mad and Myc Basic Domains Are Functionally Equivalent J. Biol. Chem., March 21, 2003; 278(13): 11094 - 11099. [Abstract] [Full Text] [PDF]

				J. C. H. Donovan, J. M. Rothenstein, and J. M. Slingerland Non-malignant and Tumor-derived Cells Differ in Their Requirement for p27Kip1 in Transforming Growth Factor-beta -mediated G1 Arrest J. Biol. Chem., October 25, 2002; 277(44): 41686 - 41692. [Abstract] [Full Text] [PDF]

				O. Jacenko, D. W. Roberts, M. R. Campbell, P. M. McManus, C. J. Gress, and Z. Tao Linking Hematopoiesis to Endochondral Skeletogenesis through Analysis of Mice Transgenic for Collagen X Am. J. Pathol., June 1, 2002; 160(6): 2019 - 2034. [Abstract] [Full Text] [PDF]

				M. E. Piedra, M. D. Delgado, M. A. Ros, and J. Leon c-Myc Overexpression Increases Cell Size and Impairs Cartilage Differentiation during Chick Limb Development Cell Growth Differ., April 1, 2002; 13(4): 185 - 193. [Abstract] [Full Text] [PDF]

				T. A. Baudino and J. L. Cleveland The Max Network Gone Mad Mol. Cell. Biol., February 1, 2001; 21(3): 691 - 702. [Full Text]

				C. Quéva, G. A. McArthur, B. M. Iritani, and R. N. Eisenman Targeted Deletion of the S-Phase-Specific Myc Antagonist Mad3 Sensitizes Neuronal and Lymphoid Cells to Radiation-Induced Apoptosis Mol. Cell. Biol., February 1, 2001; 21(3): 703 - 712. [Abstract] [Full Text]

				K.-I Lin, Y. Lin, and K. Calame Repression of c-myc Is Necessary but Not Sufficient for Terminal Differentiation of B Lymphocytes In Vitro Mol. Cell. Biol., December 1, 2000; 20(23): 8684 - 8695. [Abstract] [Full Text]

				A. N. Billin, A. L. Eilers, K. L. Coulter, J. S. Logan, and D. E. Ayer MondoA, a Novel Basic Helix-Loop-Helix-Leucine Zipper Transcriptional Activator That Constitutes a Positive Branch of a Max-Like Network Mol. Cell. Biol., December 1, 2000; 20(23): 8845 - 8854. [Abstract] [Full Text]